A carregar...
Die Prävalenz von SARS-CoV-2-IgG-AK liegt bei 1,2%: Screening bei asymptomatischen ambulanten Patienten
Patients with newly diagnosed COVID-19 (coronavirus disease 2019) develop antibodies against SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2). To date, few data have been obtained of the prevalence of SARS-CoV-2-antibodies in general population and in asymptomatic outpatients in Germany....
Na minha lista:
| Publicado no: | MMW Fortschr Med |
|---|---|
| Autor principal: | |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Springer Medizin
2020
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7417847/ https://ncbi.nlm.nih.gov/pubmed/32780376 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s15006-020-0750-y |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|